Project Number ARUK-2019DDI-CAM Agency/Funding Organization Alzheimer's Research UK Funding Year 2019 View Full Project Details for Alzheimer's Research UK Drug Discovery Institute 2018: University of Cambridge Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category C. Translational Research and Clinical Interventions 1. Research Resources and Enabling Technologies to Accelerate Therapy Development c. Translational Infrastructure Researcher and Organization Principal Investigator David Rubinsztein Principal Investigator First Name David Principal Investigator Last Name Rubinsztein Awardee Organization UNIVERSITY OF CAMBRIDGE Contact PI Country United Kingdom Project Detail FY Overall Cost $2,369,098 Funding Organization Agency/Funding Organization Alzheimer's Research UK Funding Organization Country United Kingdom
